Medicine

Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF) is pleased to announce it has entered into an agreement with Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka)

A speedy Salmonella test could help spare animals—and people—infection with one of the worst strains of the bacteria.

A discovery about the loss of synapses in diseases like Alzheimer's could offer a new treatment target.

Chronic bronchitis is a precursor to the deadly and incurable COPD, but there is no test to diagnose the disease. New research could change that.

Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams

Creating a process called endocytosis on demand could lead to new ways to deliver drugs directly to cells.

Alcon introduces new innovations in cataract surgery at European Society of Cataract & Refractive Surgeons 2017 annual congress

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has filed a Registration Statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) for a rights offering to existing holders of its common stock

Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical stage biopharmaceutical company specializing in developing novel antibiotics, today announced financial results for the half-year ended June 30, 2017

Novartis and UC Berkeley collaborate to tackle 'undruggable' disease targets

Currently, only an autopsy can detect the progressive degenerative brain disease CTE, which affects people with a history of repeated head trauma.

On September 25, FUJIFILM Corporation (President: Kenji Sukeno) invested ¥430 million in the regenerative medicine venture company NC Medical Research, Inc. with NC Medical granting Fujifilm a stock allocation

Galapagos NV and MorphoSys AG today announced Phase 1 results with their joint investigational antibody program MOR106 directed against IL-17C in patients with moderate-to-severe atopic dermatitis

Newron raises CHF 27.0 Million in a private placement of new shares